002166 莱茵生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)2.2715.2122.6637.2466.474
总资产报酬率 ROA (%)1.4073.3801.8174.6343.689
投入资产回报率 ROIC (%)1.6854.0332.1435.6074.737

边际利润分析
销售毛利率 (%)25.00129.32524.41530.79929.804
营业利润率 (%)8.37812.0467.92018.11114.427
息税前利润/营业总收入 (%)10.39513.4779.42417.57616.840
净利润/营业总收入 (%)6.2259.4356.58313.44212.455

收益指标分析
经营活动净收益/利润总额(%)81.703103.94075.37894.04478.513
价值变动净收益/利润总额(%)8.5614.42843.12016.60811.174
营业外收支净额/利润总额(%)-1.575-2.690-1.683-6.442-0.011

偿债能力分析
流动比率 (X)1.7251.7042.0322.5131.481
速动比率 (X)0.9160.9251.2221.6350.914
资产负债率 (%)36.56436.22030.72330.12641.676
带息债务/全部投入资本 (%)20.44420.77515.72613.99621.545
股东权益/带息债务 (%)359.830360.235509.482577.684335.584
股东权益/负债合计 (%)168.785171.853220.366228.331137.582
利息保障倍数 (X)4.8437.7185.76331.3306.976

营运能力分析
应收账款周转天数 (天)175.765148.472106.84276.23478.175
存货周转天数 (天)340.841312.736302.341298.241334.040